Showing results (951-960 of 1,194) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|September 14, 2016
Precise definitions of some terminology for longitudinal clinical trials: subjects, patient populations, analysis sets, intention to treat, and related termsRonald W HelmsPharmaceutical Statistics|September 3, 2016
Simulation-based sample-sizing and power calculations in logistic regression with partial prior informationAndrew P Grieve, Shah-Jalal SarkerPharmaceutical Statistics|February 9, 2010
An MSE-reduced estimator for the response proportion in a two-stage clinical trialQizhai LiPharmaceutical Statistics|December 26, 2009
Estimating time to steady state using the effective rate of drug accumulationDeborah L Panebianco, Andrea MaesPharmaceutical Statistics|April 28, 2017
Statistical modeling for Bayesian extrapolation of adult clinical trial information in pediatric drug evaluationMargaret Gamalo-Siebers, Jasmina Savic, Cynthia Basu, et al.Pharmaceutical Statistics|January 1, 2010
Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit dataShuying Yang, James RogerPharmaceutical Statistics|January 15, 2010
Reporting cumulative proportion of subjects with an adverse event based on data from multiple studiesChristy Chuang-Stein, Mohan BeltangadyPharmaceutical Statistics|May 26, 2017
An investigation into the two-stage meta-analytic copula modelling approach for evaluating time-to-event surrogate endpoints which comprise of one or more events of interestNatalie Dimier, Susan ToddPharmaceutical Statistics|May 16, 2017
Estimates of subgroup treatment effects in overall nonsignificant trials: To what extent should we believe in them?Julien Tanniou, Ingeborg van der Tweel, Steven Teerenstra, et al.Pharmaceutical Statistics|March 4, 2010
Intent-to-treat analysis in the presence of off-treatment or missing dataOliver N KeenePageof 120